Related Experiment Videos

A fourteen-year study to identify measles antigen in urine specimens by fluorescent-antibody methods

Insights

This study found that measles antigen in urine, detected by fluorescent-antibody tests, was present in 39% of measles patients. This urine test shows promise for diagnosing measles, especially when samples are collected early.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Measles is a highly contagious viral illness.
  • Accurate and timely diagnosis of measles is crucial for public health management and patient care.
  • Current diagnostic methods may have limitations in certain settings.

Purpose of the Study:

  • To evaluate the effectiveness of detecting measles antigen in urine using fluorescent-antibody methods for measles diagnosis.
  • To determine the prevalence of measles antigen in urine samples from patients with suspected measles.
  • To assess the diagnostic utility of urine testing in relation to clinical presentation and disease progression.

Main Methods:

  • Analysis of 426 morning urine specimens from 410 patients with a provisional diagnosis of measles between 1965 and 1979.
  • Application of fluorescent-antibody methods to detect measles antigen in urine sediment.
  • Comparison of urine test results with clinical assessments and subsequent disease development.

Main Results:

  • Measles antigen was detected in 33.3% of all tested urine specimens.
  • In patients clinically diagnosed with measles, 39% of urine specimens tested positive.
  • False positive results were observed in 7.8% of specimens from patients not diagnosed with measles.
  • Positive rates were highest in samples collected before or at the onset of the rash.

Conclusions:

  • Detection of measles antigen in urine sediment by fluorescent-antibody tests is a viable diagnostic approach, with a 39% positive rate in confirmed measles cases.
  • Urine testing shows potential as a diagnostic tool for measles, particularly when specimens are obtained early in the disease course.
  • Further research could explore optimizing urine sample collection timing and refining the sensitivity of fluorescent-antibody tests for broader clinical application.

Related Concept Videos